The expected end of enhanced tax credits for ACA plans and “a market-wide morbidity shift” will add to insurers’ financial ...

Analysts have provided Elevance Health with 11 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $476.73, suggesting a potential 41.8% upside.

ELEVANCE HEALTH Hedge Fund Activity We have seen 633 institutional investors add shares of ELEVANCE HEALTH stock to their portfolio, and 942 decrease their positions in their most recent quarter.

Defense stocks, fast moving foreign banks, Tesla, Alphabet and others will be in focus for stock market investors in the coming week.

Everything to Know about Macro and Markets Stock indexes fell on Friday, reversing mid‑week gains and closing in the red, as the tariff theme came ...

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...